[
  {
    "ts": null,
    "headline": "Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know",
    "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=1d7450c91744e707b2b64ebff9155972a76d5b7c2bd57ebf08a21393c23fa000",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763560803,
      "headline": "Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know",
      "id": 137548818,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=1d7450c91744e707b2b64ebff9155972a76d5b7c2bd57ebf08a21393c23fa000"
    }
  },
  {
    "ts": null,
    "headline": "Ability Biotherapeutics Expands its Scientific Advisory Board with the Appointment of Dr. John Burke and Dr. Alan Korman",
    "summary": "MONTREAL, November 19, 2025--Ability Biotherapeutics, a next-generation biotherapeutics company developing logic-gated antibodies for safer and more effective immunotherapies, announces the appointment of Dr. John Burke and Dr. Alan Korman to its Scientific Advisory Board.",
    "url": "https://finnhub.io/api/news?id=bff14941fc296fe1ededea0f03d961816a113761bbbe8891e1dd6562b1d60ad7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763556300,
      "headline": "Ability Biotherapeutics Expands its Scientific Advisory Board with the Appointment of Dr. John Burke and Dr. Alan Korman",
      "id": 137546669,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "MONTREAL, November 19, 2025--Ability Biotherapeutics, a next-generation biotherapeutics company developing logic-gated antibodies for safer and more effective immunotherapies, announces the appointment of Dr. John Burke and Dr. Alan Korman to its Scientific Advisory Board.",
      "url": "https://finnhub.io/api/news?id=bff14941fc296fe1ededea0f03d961816a113761bbbe8891e1dd6562b1d60ad7"
    }
  },
  {
    "ts": null,
    "headline": "Summit: A Cautious Bet Backed By Anti-VEGF & Insider Buying",
    "summary": "I'm rating Summit Therapeutics a 'cautious Buy' based on the promising dual-action lung cancer therapy Ivonescimab and significant insider buying.",
    "url": "https://finnhub.io/api/news?id=bd6fc09d311a6b69d44e8387a9a2dea4a4ec31b0cb6662c18963e7319db8f81f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763526394,
      "headline": "Summit: A Cautious Bet Backed By Anti-VEGF & Insider Buying",
      "id": 137544759,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2181187387/image_2181187387.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "I'm rating Summit Therapeutics a 'cautious Buy' based on the promising dual-action lung cancer therapy Ivonescimab and significant insider buying.",
      "url": "https://finnhub.io/api/news?id=bd6fc09d311a6b69d44e8387a9a2dea4a4ec31b0cb6662c18963e7319db8f81f"
    }
  }
]